The American Academy of Pediatrics says pregnant women with opioid addiction should have access to medication in new guidelines released Monday aimed at improving care for women and newborns affected by drug use
Opioid use in pregnancy has prompted new guidance from the American Academy of Pediatrics, aimed at improving care for women and newborns affected by their mothers’ drug use.
The number of affected women and infants has increased in recent years but they often don’t get effective treatment, and the pandemic may be worsening that problem, said Dr. Stephen Patrick, lead author of the academy report released Monday.
“While we have been talking about the opioid crisis for years, pregnant women and their newborns seldom make it to the top of the heap. Infants are receiving variable care and not getting connected to services,” said Patrick, a Vanderbilt University pediatrician.
The academy’s report says pregnant women should have access to opioid medication to treat opioid misuse. Two opioids, buprenorphine and methadone, are effective treatments but pregnant women often face stigma in using them and doctors who prescribe them are scarce.
The academy says hospitals should have written protocols for assessing and treating opioid-affected newborns. Many don’t and practices vary widely.
Breastfeeding and other practices that promote bonding should be encouraged, and parent education and referral to services for affected newborns should be provided, the academy says. Its recommendations echo guidance from other medical groups and the U.S. government.
“This is a substantial public health problem that is still lacking solutions,” Patrick said.
According to the federal Centers for Disease Control and Prevention, 7% of U.S. women reported in 2019 that they had used prescription opioids during pregnancy. One in 5 of those women reported misusing the drugs while pregnant.
Other opioids include heroin and fentanyl. Data suggest that use of these drugs among pregnant women increased in recent years, too.
continue reading
